title: Tamoxifen therapy for patients with breast cancer.
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Heikki
authors.initials: H
authors.lastname: Joensuu
authors.forename: Heikki
authors.initials: H
authors.lastname: Joenssu
authors.forename: Kent
authors.initials: K
authors.lastname: Osborne
authors.forename: Fatima
authors.initials: F
authors.lastname: Cardoso
authors.forename: Sybille
authors.initials: S
authors.lastname: Loibl
authors.forename: Sabine
authors.initials: S
authors.lastname: Linn
authors.forename: Aaron
authors.initials: A
authors.lastname: Goldhirsch
authors.forename: Olaf
authors.initials: O
authors.lastname: Ortmann
authors.forename: Hans Joerg
authors.initials: HJ
authors.lastname: Senn
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Hayes
mesh_terms: D000367:Age Factors; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018579:Patient Selection; D017698:Postmenopause; D017697:Premenopause; D013629:Tamoxifen / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen